ARAMIS: Actions of tesaglitazaR on fAt Metabolism and Insulin Sensitivity

NCT00263965 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

105

Enrollment

INDUSTRY

Sponsor class

Stopped The development program has been terminated

Conditions

Type 2 Diabetes

Interventions

DRUG: Tesaglitazar
DRUG: Metformin
BEHAVIORAL: Dietary and lifestyle modification counseling

Sponsor

AstraZeneca